Remove Defibrillator Remove Sudden Cardiac Death Remove Tachycardia
article thumbnail

Sudden cardiac death after acute myocarditis with arrhythmic presentation: hunting for risk predictors - a systematic review and meta-analysis

Open Heart

Possible arrhythmic recurrences and the risk of sudden cardiac death (SCD) in this setting are reasons for concern, and limited data have been published to guide clinical management of these patients. The pooled proportion of patients who experienced VA recurrence was 0.41 (95% CI 0.30 to 0.53, p=0.13).

article thumbnail

ECG Blog #436 — Bigeminy or Alternans?

Ken Grauer, MD

IMPRESSION: Given the presence of a wide tachycardia — with 2 distinct QRS morphologies, and no sign of P waves — a presumed diagnosis of B i D irectional Ventricular Tachycardia has to be made. Despite prolonged resuscitation with multiple defibrillation attempts — the patient could not be saved. =

Blog 161
article thumbnail

MP-470545-005 PREDICTORS OF MONOMORPHIC VENTRICULAR TACHYCARDIA IN PATIENTS WITH SUBCUTANEOUS IMPLANTABLE CARDIOVERTER-DEFIBRILLATORS

HeartRhythm

Subcutaneous implantable cardioverter-defibrillators (S-ICDs) alleviate many issues associated with a transvenous system, while having similar efficacy to transvenous ICDs at preventing sudden cardiac death. However, S-ICDs have higher rates of shocks due to a lack of anti-tachycardia pacing (ATP).

article thumbnail

Efficacy of Catheter Ablation for Ventricular Tachycardia in Ischemic Cardiomyopathy Patients without an ICD Implantation

HeartRhythm

Implantable cardioverter defibrillator (ICD) prevents sudden cardiac death (SCD) in patients with ischemic cardiomyopathy (ICM). Catheter ablation has been shown to effectively reduce ventricular tachycardia (VT) recurrence, yet its efficacy in patients without an ICD implantation remains uncertain.

article thumbnail

EV ICD Global Pivotal Trial Results Demonstrate High ATP Success, Effective Defibrillation

DAIC

2, 2024 – Medtronic recently shared long-term results from the global Extravascular Implantable Cardioverter Defibrillator (EV ICD) Pivotal Trial, reinforcing the performance and safety of the EV-ICD system. It works by briefly delivering pacing pulses to the heart at a rate faster than the tachycardia.

article thumbnail

Why is an Implantable Defibrillator NOT Useful Soon After Myocardial Infarction?

All About Cardiovascular System and Disorders

Here is the transcript of the video: Implantable defibrillator is an important life saving device. Then, why is it mentioned that, implanting a defibrillator soon after an acute myocardial infarction, in those with left ventricular dysfunction and prone for ventricular arrhythmias and sudden cardiac death, is not useful?

article thumbnail

PO-02-168 EVALUATION OF IMPLANTABLE CARDIOVERTER DEFIBRILLATOR ALGORITHM ACCURACY IN DIFFERENTIATING SUPRAVENTRICULAR TACHYCARDIA FROM ATRIAL FIBRILLATION.

HeartRhythm

For the past four decades, implantable cardioverter defibrillator (ICD) therapy has become the standard of care for preventing sudden cardiac death in high-risk individuals. The rate of ICD implantation has risen due to the increasing population age and the growing prevalence of cardiac arrhythmias.